What is the Global Navigator Hiroshima-Melbourne Program?
MedTech Actuator’s Global Navigator Hiroshima-Melbourne Program is a global growth-stage market access program that enables healthcare startups to initiate their global business strategy, while leveraging the knowledge and support of the Australian ecosystem.
The program facilitates the planning and implementation of quick and effective international strategies through seminar sessions and a local in-person immersion trip to Melbourne, Australia, with visits to local organizations, including government agencies, medical institutions, companies, and meetings with key opinion leaders (KOLs).
Why Australia?
Australia is one of Asia-Pacific’s fastest-growing startup ecosystems. In 2021, Australian BioTech/MedTech startups raised over A$500 million capital – the 5th largest sector in Australia. In Singapore & Australia, the startup ecosystem’s value has grown by more than AUD$7 billion in the past 12 months to more than AUD$17 billion (The Global Startup Ecosystem Report, 2022) and the city flourishes as a top five life science hub in Asia-Pacific and Australia (CBRE, 2021).
MedTech Actuator’s Global Navigator Hiroshima-Melbourne is looking for passionate founders and startups to grow their venture and transform global healthcare. Apply today!
Program activities:
2 days of seminar from industry expert seminars and pitching practice carried out in-person (Hiroshima)
Australia Immersion – 3 days of learning, networking and exploring Australia’s innovation ecosystems.
Program will be delivered in English
プログラムは英語で提供されます
Learn 学ぶ
from industry experts, founders, and MedTech Actuator
Discover 発見する
different startup ecosystem in Australia
Network ネットワーキング
connect with clinical experts and commercial stakeholders in the Australian MedTech, BioTech and HealthTech startup ecosystem
Expand 拡大する
your startup into the Australian market efficiently
Program Key Dates (2024-2025)
Applications Period
18th Nov to 4th Dec 2024
Teams Selected
9th Dec 2024
Onboarding Session
11th Dec 2024
In-Person Seminars (Hiroshima)
19th & 20th Dec 2024
Visit to Australia
1st Week of March 2025
Program Eligibility
▶️ Only startups from Hiroshima and surrounded area.
▶️ Healthcare focus - Companies/products in human health only.
▶️ Product Maturity: The startup should have a minimum viable product (MVP) or prototype and must have conducted initial trials or tests within Japan. Early-stage ideas or concepts without a working product may not be eligible.
Selection Criteria
▶️ Have a keen interest in expanding out of Japan into international markets in particular Australia, Singapore, the USA and Europe.
▶️ Company maturity: be suitably resourced and be ready to commence overseas expansion.
▶️ Have a clear goal(s) on what you want from the immersion program (e.g. clinical trials, finding KOL, looking for distributors, R&D collaborations etc.). Companies with multiple goals in mind may have a higher chance of success.
▶️ Likelihood of the technology and company benefiting from the program activities and connections available through the program.
▶️ Have the ability to send a suitable senior company delegate to participate in the program.
▶️ Cohort dynamics (consideration for like technologies).
▶️ English level (business level proficiency preferred).
Need help? Speak with us / 問い合わせ
Please reach out to the team if you have any questions about your eligibility.
